Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Technovax, Inc. in August, 2020 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI145499-01A1 | Phase I | 300,000 | August 3, 2020 | |||||||
A SBIR Phase II contract was awarded to Technovax, Inc. in September, 2018 for $1,481,143.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI106145-03 | Phase II | 1,481,143 | September 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Technovax, Inc. in September, 2019 for $1,074,853.0 USD from the U.S. Department of Defense and Defense Health Agency. | SBIR | W81XWH19C0169 | Phase II | 1,074,853 | September 16, 2019 | |||||||
A SBIR Phase II contract was awarded to Technovax, Inc. in September, 2016 for $1,999,175.0 USD from the U.S. Department of Defense. | SBIR | W81XWH-16-C-0113 | Phase II | 1,999,175 | September 28, 2016 | |||||||
A SBIR Phase I contract was awarded to Technovax, Inc. in September, 2015 for $100,000.0 USD from the U.S. Department of Defense. | SBIR | W81XWH-15-C-0178 | Phase I | 100,000 | September 25, 2015 | |||||||
A SBIR Phase II contract was awarded to Technovax, Inc. for $2,947,510.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI063830-03A1 | Phase II | 2,947,510 | ||||||||
A SBIR Phase I contract was awarded to Technovax, Inc. for $1,010,040.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI063830-01 | Phase I | 1,010,040 | ||||||||
A SBIR Phase I contract was awarded to Technovax, Inc. for $509,623.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI108099-01A1 | Phase I | 509,623 | ||||||||
A SBIR Phase I contract was awarded to Technovax, Inc. for $600,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI106145-01A1 | Phase I | 600,000 |